A quasi-optimal non-coplanar 4π-VMAT solution for treating head & neck cancers
Joe Simms,
United Kingdom
MO-0545
Abstract
A quasi-optimal non-coplanar 4π-VMAT solution for treating head & neck cancers
Authors: Joe Simms1, Carl Rowbottom2, Russell Dawson2
1The Clatterbridge Cancer Centre, Radiotherapy Physics , Liverpool, United Kingdom; 2The Clatterbridge Cancer Centre, Radiotherapy Physics, Liverpool, United Kingdom
Show Affiliations
Hide Affiliations
Purpose or Objective
Patients
treated with radiotherapy for H&N cancer unfortunately suffer from high
rates of post treatment complications, due to the significant number of
radiosensitive OARs within close proximity to large tumour volumes. Non-coplanar 4π-VMAT with increased
degrees of freedom has the potential to create more conformal plans that would
likely benefit this patient group. The aim of this study was to develop and
independently test a quasi-optimal non-coplanar
4π-VMAT configuration.
Material and Methods
The study was divided into two main phases. In phase
one, a cohort of ten previously treated H&N patients were replanned using a
12-arc plan; 11 non-coplanar arcs and a coplanar arc. The 12-arc plans were
reduced to a single arc plan by using an iterative algorithm based on MU. The
arc contributing the fewest MU was deleted from the plan, the plan re-optimised
and the process repeated. Consequently, it was possible to determine how the
number of arcs in a plan affects certain dose metrics and which couch rotation
angles seem preferable for this patient group.
In phase 2, a preferred non-coplanar 4π-VMAT configuration
developed from phase 1 was applied to an independent cohort of ten H&N patients,
and the effect on OAR doses assessed. The resulting plans were delivered and
timed for comparison with the standard 2-arc coplanar approach.
Results
The
gradient index, along with spinal canal and parotid doses, were minimised when
as few as three non-coplanar arcs
were used. In addition, non-coplanar
arcs with large couch rotation angles survived for longer during the iterative
process and therefore were deemed superior. In phase two, statistically
significant dose reductions were obtained when using a 4-arc solution consisting
of a coplanar arc and three non-coplanar
arcs with 90° and ±75° couch rotations. These included mean reductions in the
doses to the spinal canal D0.1cc (3.83±1.33 Gy, p < 0.001),
brainstem D0.1cc (5.15±3.71 Gy, p = 0.019), contra-lateral parotid Dmean
(3.83±2.06 Gy, p = 0.005) and ipsi-lateral parotid Dmean (4.18±1.99 Gy,
p = 0.002). The mean delivery time was 450±32 s, compared to 170±9 s for the
original, 2-arc coplanar plans. The 4π-VMAT delivery time can likely be reduced
via intelligent sequencing of arcs to minimise gantry/couch rotations and
applying single button press delivery techniques. Assessing the dosimetric
accuracy of these plans will form part of the ongoing work.
Conclusion
By using a simple,
iterative algorithm, a quasi-optimal non-coplanar class-solution was developed from
a small cohort of patients. Non-coplanar VMAT for H&N cancer shows promise
in reducing OAR doses and therefore side effects from treatment.